PS
Patrick F Smith
President, Drug Dev Solutions

Patrick F Smith insider trades: Certara (CERT) stock sales

President, Drug Dev Solutions, Certara Last trade Oct 7, 2024 14 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2022
1
Company
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Patrick reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 7, 2024CERT↓ Sell$60K
Apr 2, 2024CERT↓ Sell$243K
Feb 20, 2024CERT↓ Sell$90K
Jun 5, 2023CERT↓ Sell$412K
Nov 9, 2022CERT↓ Sell$32K
Aug 16, 2022CERT↓ Sell$177K
Jun 8, 2022CERT↓ Sell$192K
Apr 4, 2022CERT↓ Sell$75K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CERT insiders

Open-market trades in the last 12 months

About Patrick F Smith's insider trades

Patrick F Smith is President, Drug Dev Solutions at Certara (CERT). Since Apr 4, 2022, Patrick has reported no open-market purchases and 8 sales worth $1.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include shares withheld for taxes (5 filings), grants and awards (4 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CERT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.